DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
Cynthia Bernier(Occupational Cancer Research Centre), Anne Roulston(Goodman (Japan)), Paul Savage(Unknown), Michel Gravel(University of Lübeck), Ahmed Soliman(Goodman (Japan)), Peter M. Siegel(L'Oréal (France)), Matthew Dankner(McGill University), Morag Park(McGill University Health Centre), Gordon C. Shore(McGill University), Kevin Petrecca(McGill University Health Centre)
Cited by 22
Related Papers
Intraoperative brain cancer detection with Raman spectroscopy in humans
|Science Translational Medicine|2015|625
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
|Nature Communications|2020|601
MAFG-driven astrocytes promote CNS inflammation
|Nature|2020|510